1. Home
  2. IDA vs BLCO Comparison

IDA vs BLCO Comparison

Compare IDA & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDACORP Inc.

IDA

IDACORP Inc.

HOLD

Current Price

$141.92

Market Cap

7.8B

Sector

Utilities

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.19

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDA
BLCO
Founded
1915
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Electric Utilities: Central
Ophthalmic Goods
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8B
6.0B
IPO Year
1998
2022

Fundamental Metrics

Financial Performance
Metric
IDA
BLCO
Price
$141.92
$16.19
Analyst Decision
Buy
Buy
Analyst Count
7
12
Target Price
$139.57
$18.55
AVG Volume (30 Days)
403.1K
444.0K
Earning Date
05-22-2026
05-21-2026
Dividend Yield
2.50%
N/A
EPS Growth
7.27
N/A
EPS
5.90
N/A
Revenue
$1,746,972,000.00
$5,101,000,000.00
Revenue This Year
$10.87
$8.61
Revenue Next Year
$12.99
$5.52
P/E Ratio
$23.91
N/A
Revenue Growth
N/A
6.47
52 Week Low
$109.30
$10.45
52 Week High
$145.94
$18.92

Technical Indicators

Market Signals
Indicator
IDA
BLCO
Relative Strength Index (RSI) 55.94 34.79
Support Level $138.41 $14.39
Resistance Level $145.37 $17.44
Average True Range (ATR) 2.58 0.52
MACD -0.62 -0.21
Stochastic Oscillator 45.67 3.47

Price Performance

Historical Comparison
IDA
BLCO

About IDA IDACORP Inc.

Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The company's only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which are involved in food processing, electronics and general manufacturing, agriculture, health care, government, education, and information technology.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: